On Dec. 10, 2021, the World Health Organization announced interim recommendations for the use of the Janssen Ad26.COV2.S…
On Dec. 9, 2021, CytoDyn announced that it had submitted a Phase 3, randomized, double blind, placebo controlled…
On Dec. 9, 2021, Moderna announced the launch of its Artificial Intelligence Academy, an innovative initiative that will…
On Dec. 9, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had expanded…
On Dec. 8, 2021, Pfizer and BioNTech announced results from an initial laboratory study demonstrating that serum antibodies…
On Dec. 8, 2021, PerkinElmer announced the research use only launch of the NEXTFLEXï¾® Variant-Seqï¾™ SARS-CoV-2 Kit v2…
On Dec. 8, 2021, Alberta announced it can track the prevalence of COVID-19 infections in nearly 75 per…
On Dec. 8, 2021, the U.S. Food and Drug Administration issued an emergency use authorization for AstraZenecaï¾’s Evusheld…
On Dec. 7, 2021, Arbutus Biopharma, X-Chem, and Proteros announced that Arbutus had identified several molecules that inhibit…
On Dec. 7, 2021, Rockefeller University scientists announced a study had demonstrated the therapeutic potential of an unusual…
On Dec. 6, 2021, the USAID announced the foundation of a new whole-of-government effort, the Initiative for Global…
On Dec. 6, 2021, Roche announced that its planned to launch the SARS-CoV-2 & Flu A/B Rapid Antigen…
On Dec. 6, 2021, Roche announced that the European Medicines Agencyï¾’s Committee for Medicinal Products for Human Use…
On Dec. 5, 2021, Sorrento Therapeutics announced the peer-reviewed publication of a series of novel SARS-CoV-2 MPro inhibitors…
On Dec. 5, 2021, Johnson & Johnson announced preliminary results from an independent study, including a subset of…
On Dec. 3, 2021, a report from the U.S. Department of Health and Human Services (HHS) found that…
On Dec. 1, 2021, T2 Biosystems announced that its T2SARS-CoV-2 Panel detected the Omicron COVID-19 variant (B.1.1.529). To…
On Dec. 1, 2021, Fulgent Genetics confirmed that the Companyï¾’s RT-PCR test for SARS-CoV-2, the virus that causes…
On Dec. 1, 2021, Moderna announced a revised supply agreement with the UK government for up to 60…
On Dec. 1, 2021, the California and San Francisco Departments of Public Health confirmed that a recent case…
On Nov. 30, 2021, Inovio Pharma announced the company was rapidly moving to evaluate its COVID-19 DNA vaccine…
On Nov. 30, 2021, LabCorp announced that it had begun offering observed self-collection for COVID-19 PCR testing in…
On Nov. 29, 2021, Thermo Fisher Scientific confirmed that its polymerase chain reaction (PCR) TaqPath COVID-19 Combo Kit…
On Nov. 29, 2021, Hologic announced that its three SARS-CoV-2 tests all detected the recently emerged Omicron variant…
The COVID-19 Roller Coaster is a wild ride, strap yourself in and hold on… Cast of Characters: Senator…
On Nov. 26, 2021, Merck provided an update on the MOVe-OUT study of molnupiravir, an investigational oral antiviral…
On Nov. 25, 2021, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
On Nov. 24, 2021, Novavax announced its submission to the Singapore Health Sciences Authority for interim authorization of…
On Nov. 24, 2021, Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) had issued Emergency…
On Nov. 23, 2021, the World Health Organization’s COVID-19 Technology Access Pool and the Medicines Patent Pool finalized…